Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2017 Financial Results
May 09, 2017 12:01 pm UTC| Business
AUSTIN, Texas, May 09, 2017 -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases...
Semtech Joins Smart Cities Council to Collaborate on Smart City IoT Solutions
May 09, 2017 12:01 pm UTC| Business
CAMARILLO, Calif., May 09, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, announced it has joined the Smart Cities Council and is participating in Smart Cities...
Icahn Enterprises L.P. Reports First Quarter 2017 Financial Results
May 09, 2017 12:01 pm UTC| Business
NEW YORK, May 09, 2017 -- Icahn Enterprises L.P. (NASDAQ:IEP) is reporting first quarter 2017 revenues of $4.7 billion and net loss attributable to Icahn Enterprises of $18 million, or a loss of $0.12 per depositary...
Amyris to Announce First Quarter 2017 Financial Results on Monday, May 15, 2017
May 09, 2017 12:01 pm UTC| Business
EMERYVILLE, Calif., May 09, 2017 -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2017 after market close on Monday, May 15, 2017. The company will hold its quarterly...
Burcon Updates on Peazazz® and Multiple Patent Grants
May 09, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, May 09, 2017 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) is pleased to announce today that it has been granted a U.S. patent, covering technology for the production...
Sigma Labs to Unveil PrintRite3D® INSPECT™ V.2.0 at RAPID 2017
May 09, 2017 12:01 pm UTC| Business
SANTA FE, N.M., May 09, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced it will unveil its PrintRite3D®...
Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11
May 09, 2017 12:01 pm UTC| Business
NEW YORK, May 09, 2017 -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for its...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes